4 results match your criteria: "The No.1 Hospital of Jilin University[Affiliation]"
Eur Rev Med Pharmacol Sci
January 2021
Department of Pediatric Surgery, The No. 1 Hospital of Jilin University, Changchun, Jilin, China.
The article "MicroRNA-32 inhibits the proliferation, migration and invasion of human colon cancer cell lines by targeting E2F transcription factor 5, by F. Yang, L. Chen, Z.
View Article and Find Full Text PDFMedicine (Baltimore)
July 2020
Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University.
Rationale: Adult intussusception is rarely observed, accounting for about 5% of all cases of intussusception. Most ileal lipomas are asymptomatic and do not need any special treatment. Herein, we describe a case with ileocolic intussusception caused by ileal lipoma.
View Article and Find Full Text PDFEur Rev Med Pharmacol Sci
May 2019
Department of Pediatric Surgery, The No. 1 Hospital of Jilin University, Changchun, Jilin, China.
Objective: MicroRNAs to be essential therapeutic targets for the treatment of diseases such as cancer. Colon cancer is one of the prevalent cancers and causes tremendous human mortality. The treatment of colon cancer is limited by late diagnosis and lack of efficient therapeutic targets.
View Article and Find Full Text PDFBMC Cancer
March 2018
Department of Pediatric Immunology, Allergy and Rheumatology, The No.1 Hospital of Jilin University, Changchun, China.
Background: Desmoplastic small round cell tumor (DSRCT) is a rare malignant sarcoma with poor prognosis due to lack of effective treatments. Apatinib is a new potent oral small-molecule tyrosine kinase inhibitor, and targets the intracellular domain of vascular endothelial growth factor receptor 2 (VEGFR-2). In this study, we presented a case of intra-abdominal DSRCT which was effectively treated by apatinib.
View Article and Find Full Text PDF